Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Se

Discussion Board Forums Clinical Trials Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Se

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #97810
    gavin
    Moderator

    Hi Kgroft,

    Glad to be of help as always. Thanks for letting us know about your husband and I am very happy to hear how he is getting on with this. I will keep my fingers crossed for him for further great responses to the treatment and please if you can keep letting us know how things go with this. We are here for you.

    My best wishes to you both,

    Gavin

    #97800
    kgroft
    Participant

    I’m so happy to say my husband is in cohort A and is one of the 19 individuals with Partial Response:  he’s had 69% total shrinkage, even though he missed two cycles of the med due to surgery and a hospitalization.  This drug has been an incredible gift for him. Our nurse explained that those with FGFR2 KIAA 12-17 seem to have the best response.

     

    Thank you VERY much for posting the link to the article. 🙂

    #97687
    gavin
    Moderator

    Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma

    https://investor.incyte.com/news-releases/news-release-details/incyte-announces-positive-interim-data-phase-2-trial-pemigatinib

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.
©2017 - All Rights Reserved, Cholangiocarcinoma Foundation